Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study
Titel:
Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study
Auteur:
Lee, Chung-Han Shah, Amishi Yogesh Rasco, Drew Rao, Arpit Taylor, Matthew H Di Simone, Christopher Hsieh, James J Pinto, Alvaro Shaffer, David R Girones Sarrio, Regina Cohn, Allen Lee Vogelzang, Nicholas J Bilen, Mehmet Asim Gunnestad Ribe, Sara Goksel, Musaberk Tennøe, Øyvind Krohn Richards, Donald Sweis, Randy F Courtright, Jay Heinrich, Daniel Jain, Sharad Wu, Jane Schmidt, Emmett V Perini, Rodolfo F Kubiak, Peter Okpara, Chinyere E Smith, Alan D Motzer, Robert J